GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

T&R Biofab Co 246710.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

1,724

+0.06%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩26.97bn

FY2016FY2025

Net income

−₩31.95bn

FY2016FY2025

Free cash flow

−₩9.87bn

FY2016FY2025

Shareholders' equity

₩26.07bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₩26.97bn₩4.87bn₩5.20bn₩5.75bn₩3.23bn₩6.81bn₩1.29bn₩974.3m₩405.5m₩274.2m
Research and development₩4.52bn₩5.51bn₩4.40bn₩3.47bn₩2.82bn₩3.33bn₩2.23bn₩1.96bn₩1.65bn₩384.8m
Operating income−₩8.57bn−₩8.77bn−₩13.54bn−₩8.04bn−₩10.68bn−₩5.51bn−₩6.86bn−₩4.93bn−₩4.16bn−₩3.10bn
Net income−₩31.95bn−₩7.68bn−₩13.42bn−₩10.34bn−₩11.08bn−₩5.60bn−₩6.25bn−₩4.69bn−₩4.06bn−₩3.02bn
Diluted earnings per share-3,827.53-919.87-1,607.50-1,238.31-1,327.70-671.37-748.83-562.23-486.13-361.76

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₩92.71bn₩98.45bn₩99.82bn₩75.94bn₩82.23bn₩48.51bn₩27.09bn₩31.10bn₩9.47bn₩9.59bn
Cash and short-term investments—₩17.28bn₩51.75bn₩40.42bn₩58.17bn₩36.88bn₩21.72bn₩28.83bn₩7.80bn₩8.06bn
Total liabilities₩66.64bn₩74.24bn₩68.62bn₩36.67bn₩40.54bn₩2.45bn₩2.33bn₩837.1m₩395.5m₩738.4m
Debt₩23.07bn₩22.94bn₩16.70bn₩6.71bn₩29.81bn₩497.9m₩649.9m——₩200.0m
Shareholders' equity₩26.07bn₩24.21bn₩31.20bn₩39.26bn₩41.69bn₩46.05bn₩24.76bn₩30.27bn₩9.07bn₩8.85bn
Shares outstanding8m8m8m8m8m8m8m8m8m8m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−₩7.47bn−₩11.73bn−₩6.96bn−₩5.89bn−₩7.56bn−₩8.38bn−₩5.17bn−₩5.66bn−₩3.72bn−₩2.59bn
Capital spending−₩2.40bn−₩2.81bn−₩12.73bn−₩10.83bn−₩1.13bn−₩1.69bn−₩668.0m−₩452.3m−₩214.1m−₩643.7m
Free cash flow−₩9.87bn−₩14.54bn−₩19.69bn−₩16.71bn−₩8.69bn−₩10.06bn−₩5.84bn−₩6.11bn−₩3.94bn−₩3.23bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩9.54bn₩8.72bn₩7.52bn₩6.95bn₩6.54bn₩5.96bn₩1.23bn₩1.10bn
Operating income−₩953.5m−₩881.6m−₩1.91bn—₩116.7m−₩4.64bn₩4.96bn−₩4.06bn
Net income−₩3.78bn−₩1.66bn−₩16.56bn−₩5.71bn−₩4.29bn−₩5.39bn₩5.79bn−₩4.77bn
Diluted earnings per share-453.12-198.98-1,983.20-684.41-513.87-646.05693.58-570.88
Cash from operations−₩1.05bn₩360.0m−₩1.57bn₩17.0m−₩1.11bn−₩4.80bn−₩11.73bn−₩8.04bn
Capital spending−₩855.0m−₩661.0m−₩559.0m−₩566.0m−₩979.0m−₩295.0m−₩2.81bn−₩2.37bn
Free cash flow−₩1.91bn−₩301.0m−₩2.13bn−₩549.0m−₩2.09bn−₩5.09bn−₩14.54bn−₩10.42bn
Total assets₩92.75bn₩92.17bn₩92.71bn₩83.86bn₩94.92bn₩93.87bn₩98.45bn₩75.41bn
Cash and short-term investments—————₩11.81bn₩17.28bn₩23.23bn
Debt₩16.05bn₩23.41bn₩23.07bn₩22.65bn₩21.30bn₩23.54bn₩22.94bn₩16.40bn
Shareholders' equity₩21.20bn₩24.41bn₩26.07bn₩11.31bn₩17.40bn₩18.96bn₩24.21bn₩18.36bn

Financial ratios

Data as of 6 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Operating margin-31.8%-179.9%-260.5%-139.8%-330.1%-81.0%—
Net margin-118.5%-157.6%-258.1%-179.6%-342.6%-82.4%—
Return on equity-122.6%-31.7%-43.0%-26.3%-26.6%-12.2%—
Return on assets-34.5%-7.8%-13.4%-13.6%-13.5%-11.6%—
Free cash flow yield——————-24.4%
Revenue growth453.3%-6.3%-9.7%77.9%-52.5%428.7%—
Earnings growth316.1%-42.8%29.8%-6.7%97.8%-10.3%—
Current ratio1.32x0.64x1.13x1.61x42.67x35.42x—
Debt to equity0.88x0.93x0.52x0.16x0.70x0.00x—
Equity ratio28.1%24.6%31.3%51.7%50.7%94.9%—
Interest coverage-1.41x-3986.96x-4175.35x-3.13x-225.62x-349.17x—
R&D as a share of sales16.8%113.0%84.6%60.3%87.1%49.0%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue67.3%31.7%80.6%
Operating income2.1%9.2%22.7%
Net income45.7%41.6%38.4%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-54.5%-91.0%-104.3%-134.8%
Net margin-124.5%-148.1%-151.6%-177.9%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Price to earnings-1.0-3.1-3.7-6.1-12.5-8.3-4.4-5.3
Price to sales1.24.99.511.042.96.821.525.3

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 6-for-5 split · 29 Oct 2025
  • 164-for-139 split · 9 Sept 2025
  • 2-for-1 split · 5 Apr 2022

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.